Semaglutide improves walk distance for PAD patients with diabetes - report from ACC.25

from Medical Digest & Congress Report · host Medical Congress News

Marc P. Bonaca explains semaglutide significantly improved maximal walking distance in people with symptomatic peripheral arterial disease and type 2 diabetes in a trial designed to evaluate the use of a GLP-1 agonist to manage PAD, according to a study presented at the American College of Cardiology’s Annual Scientific Session. Video: https://medicaldigest.org/scientific-contents/interview:semaglutide-improves-walk-distance-pad-patients-diabetes

Episode metadata supplied by the publisher feed · Published Apr 4, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Semaglutide improves walk distance for PAD patients with diabetes - report from ACC.25

0:00 5:52

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 5 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on April 4, 2025.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!